Mettler-Toledo International, Inc. (NYSE:MTD) Shares Purchased by Crown Oak Advisors LLC

Crown Oak Advisors LLC raised its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 5.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,942 shares of the medical instruments supplier's stock after acquiring an additional 298 shares during the period. Mettler-Toledo International makes up 3.5% of Crown Oak Advisors LLC's holdings, making the stock its 14th largest position. Crown Oak Advisors LLC's holdings in Mettler-Toledo International were worth $7,017,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC increased its stake in shares of Mettler-Toledo International by 1.2% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,255 shares of the medical instruments supplier's stock valued at $1,532,000 after acquiring an additional 15 shares during the period. Allworth Financial LP boosted its stake in Mettler-Toledo International by 367.4% during the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after purchasing an additional 169 shares in the last quarter. Sanctuary Advisors LLC increased its position in shares of Mettler-Toledo International by 3.3% during the 4th quarter. Sanctuary Advisors LLC now owns 534 shares of the medical instruments supplier's stock valued at $653,000 after purchasing an additional 17 shares during the period. CIBC Asset Management Inc raised its stake in shares of Mettler-Toledo International by 4.1% in the 4th quarter. CIBC Asset Management Inc now owns 3,235 shares of the medical instruments supplier's stock worth $3,959,000 after buying an additional 128 shares in the last quarter. Finally, Truist Financial Corp lifted its holdings in shares of Mettler-Toledo International by 1.3% in the fourth quarter. Truist Financial Corp now owns 1,053 shares of the medical instruments supplier's stock valued at $1,289,000 after buying an additional 14 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,150.94 on Wednesday. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,546.93. The firm has a market capitalization of $23.92 billion, a price-to-earnings ratio of 28.70, a P/E/G ratio of 3.50 and a beta of 1.38. The company has a 50 day moving average price of $1,111.61 and a 200 day moving average price of $1,202.84.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The company had revenue of $883.74 million during the quarter, compared to analyst estimates of $876.61 million. During the same quarter in the prior year, the company earned $8.89 earnings per share. The company's revenue for the quarter was down 4.6% on a year-over-year basis. Equities analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the transaction, the director now directly owns 120 shares of the company's stock, valued at approximately $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.77% of the company's stock.

Wall Street Analysts Forecast Growth

MTD has been the topic of several research reports. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a research report on Monday, April 7th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their target price for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their price target for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Wall Street Zen cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Finally, Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $1,302.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.